Corrigendum to “Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients” [EBioMedicine 37 (2018) 134–143]

The authors noticed that FACS data has been duplicated by mistake in Figs. 5e and i in the published version of this article. Below is the corrected version of Fig. 5 with the correct image for the Fig. 5i. This change does not affect the results or conclusions of this study, and the authors sincerely apologize for any inconvenience caused by this mistake.

Fig. 5.

The effect of SETD7 knockdown (a, b) Cell viability of SETD7 knockdown HCT116 and RKO cells. (c, d) Cell cycle analysis of SETD7 knockdown HCT116 and RKO cells. (e–l) Cell apoptosis analysis of SETD7 knockdown HCT116 and RKO cells. (∗∗∗ indicates P < 0.001, ∗∗ indicates P < 0.01, ∗ indicates P < 0.05).